NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

You're actually suggesting you know this investor's intention, which is quick profit. Fourteen million shares at $.38 is quite an investment. Here's the thing, it's not so easy to flip that many shares without a catalyst. One must be coming. Fourteen million shares were bought before a report out which is expected next month. That is risky move; one would think the investor knows what they bought will go up in value. If DCVax-L fails the Phase III study this investor made a bad deal. If the DCVax-L study is successful the investor made a good deal. If you're correct than this investor is expecting the stock not fall below $.38. This investor bought a long position. Period.